Genomics

Dataset Information

KDM5 inhibition is a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas [1]


ABSTRACT: KDM5 inhibition is a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas [1]

PROVIDER: PRJNA471534 | ENA |

REPOSITORIES: ENA